Abstract
An analysis has been carried out to investigate the ability of neoplastic cells from the mouse B-cell leukaemia (BCL1) to secrete idiotypic IgM. Tumour cells taken from the spleen and placed in short-term culture without stimulation secreted quite large amounts of idiotypic IgM with a mean value for six animals +/- SD of 11,5000 +/- 6800 molecules of pentamer/cell/hr, with levels increasing steadily over a 7-hr period. Tumour cells from the blood of matched animals also secreted idiotypic IgM in amounts generally less than the spleen cells (4100 +/- 2000 molecules/cell/hr. The IgM produced was found to be mainly pentameric, with some material of lower molecular weight. This idiotypic IgM could also be detected in the serum of leukaemic animals as pentameric IgM, and amounts increased during tumour development to 1-2 mg/ml in the terminal phase of disease. Since binding of anti-idiotypic antibody to tumour cells is inhibited by this material, it should be taken into account in immunotherapeutic schedules involving such antibody. However, it also presents a useful marker of disease, and perhaps of response to therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brooks K., Yuan D., Uhr J. W., Krammer P. H., Vitetta E. S. Lymphokine-induced IgM secretion by clones of neoplastic B cells. Nature. 1983 Apr 28;302(5911):825–826. doi: 10.1038/302825a0. [DOI] [PubMed] [Google Scholar]
- Isakson P. C., Uhr J. W., Krolick K. A., Finkelman F., Vitetta E. S. Acquisition of cell surface IgD after in vitro culture of neoplastic B cells from the murine tumor BCL1. J Exp Med. 1980 Mar 1;151(3):749–754. doi: 10.1084/jem.151.3.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krolick K. A., Isakson P. C., Uhr J. W., Vitetta E. S. BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. Immunol Rev. 1979;48:81–106. doi: 10.1111/j.1600-065x.1979.tb00299.x. [DOI] [PubMed] [Google Scholar]
- Slavin S., Strober S. Spontaneous murine B-cell leukaemia. Nature. 1978 Apr 13;272(5654):624–626. doi: 10.1038/272624a0. [DOI] [PubMed] [Google Scholar]
- Stevenson F. K., Gregg E. O., Smith J. L., Stevenson G. T. Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma. Br J Cancer. 1984 Nov;50(5):579–586. doi: 10.1038/bjc.1984.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stevenson F. K., Hamblin T. J., Stevenson G. T., Tutt A. L. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med. 1980 Dec 1;152(6):1484–1496. doi: 10.1084/jem.152.6.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stevenson F. K., Morris D., Stevenson G. T. Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load. Immunology. 1980 Oct;41(2):313–321. [PMC free article] [PubMed] [Google Scholar]
- Stevenson G. T., Stevenson F. K. Treatment of lymphoid tumors with anti-idiotype antibodies. Springer Semin Immunopathol. 1983;6(1):99–115. doi: 10.1007/BF01857369. [DOI] [PubMed] [Google Scholar]
- Strober S., Gronowicz E. S., Knapp M. R., Slavin S., Vitetta E. S., Warnke R. A., Kotzin B., Schröder J. Immunobiology of a spontaneous murine B cell leukemia (BCL1). Immunol Rev. 1979;48:169–195. doi: 10.1111/j.1600-065x.1979.tb00303.x. [DOI] [PubMed] [Google Scholar]
- Tutt A. L., Stevenson F. K., Smith J. L., Stevenson G. T. Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes. J Immunol. 1983 Dec;131(6):3058–3063. [PubMed] [Google Scholar]
- Vitetta E. S., Krolick K. A., Uhr J. W. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins. Immunol Rev. 1982;62:159–183. doi: 10.1111/j.1600-065x.1982.tb00393.x. [DOI] [PubMed] [Google Scholar]